JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DOWNES, H.
Right arrow Articles by WILLIAMS, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DOWNES, H.
Right arrow Articles by WILLIAMS, J. K.
Journal of Pharmacology And Experimental Therapeutics, Vol. 168, Issue 2, 283-289, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF A CONVULSANT BARBITURATE ON THE SPINAL MONOSYNAPTIC PATHWAY

HALL DOWNES 1 and JOHN K. WILLIAMS 1

1 Department of Pharmacology, University of Utah College of Medicine, Salt Lake City, Utah

The monosynaptic (2N) reflex was recorded electrically from the seventh lumbar or first sacral ventral roots of 37 unanesthetized spinal cats. In i.v. doses of 0.3 to 0.6 mg/kg, the convulsant barbiturate, 5-(2-cyclohexylideneëthyl)-5-ethyl barbituric acid, produced a prominent increase in the 2N response. Accompanying changes in presynaptic and postsynaptic inhibition did not account adequately for the increase in the 2N response. Pentobarbital Na in low i.v. doses (2 mg/kg) produced an increase in the 2N response of lesser extent and duration; after pentobarbital, the effect of the convulsant barbiturate was markedly diminished. The antagonism was reversible, and depression of the 2N response produced by larger doses of pentobarbital was reversed by larger doses of the convulsant barbiturate.

Submitted on October 29, 1968
Accepted on April 1, 1969




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
J. H. Lin and A. Y. H. Lu
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development
Pharmacol. Rev., December 1, 1997; 49(4): 403 - 449.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.